PEPPOLONI, Samuele
 Distribuzione geografica
Continente #
EU - Europa 21.800
NA - Nord America 16.732
AS - Asia 7.802
SA - Sud America 934
Continente sconosciuto - Info sul continente non disponibili 394
AF - Africa 172
OC - Oceania 19
Totale 47.853
Nazione #
US - Stati Uniti d'America 16.279
IT - Italia 15.840
SG - Singapore 2.760
GB - Regno Unito 2.218
CN - Cina 2.014
HK - Hong Kong 929
DE - Germania 746
FR - Francia 696
BR - Brasile 679
VN - Vietnam 671
SE - Svezia 655
UA - Ucraina 350
RU - Federazione Russa 290
BD - Bangladesh 285
FI - Finlandia 272
TR - Turchia 244
KR - Corea 210
IN - India 181
CA - Canada 171
MX - Messico 133
BG - Bulgaria 122
NL - Olanda 105
AR - Argentina 95
ID - Indonesia 81
AT - Austria 80
IQ - Iraq 67
PL - Polonia 63
BE - Belgio 51
JP - Giappone 51
RO - Romania 49
ZA - Sudafrica 48
ES - Italia 41
IE - Irlanda 41
PK - Pakistan 36
AE - Emirati Arabi Uniti 34
CH - Svizzera 33
MA - Marocco 33
CO - Colombia 32
CL - Cile 28
VE - Venezuela 28
IL - Israele 27
CR - Costa Rica 25
EC - Ecuador 25
UZ - Uzbekistan 24
MY - Malesia 22
PH - Filippine 22
HN - Honduras 21
PT - Portogallo 21
LT - Lituania 19
CZ - Repubblica Ceca 18
KE - Kenya 18
AU - Australia 17
IR - Iran 17
PY - Paraguay 17
TH - Thailandia 17
TT - Trinidad e Tobago 16
JO - Giordania 15
PR - Porto Rico 14
DK - Danimarca 12
EG - Egitto 12
SC - Seychelles 12
EE - Estonia 11
NP - Nepal 11
PE - Perù 11
SA - Arabia Saudita 11
TN - Tunisia 11
DZ - Algeria 10
GP - Guadalupe 10
SV - El Salvador 10
TW - Taiwan 10
GT - Guatemala 9
KG - Kirghizistan 9
UY - Uruguay 9
AL - Albania 8
AZ - Azerbaigian 8
DO - Repubblica Dominicana 7
EU - Europa 7
JM - Giamaica 7
NI - Nicaragua 7
NO - Norvegia 7
PA - Panama 7
BO - Bolivia 6
GR - Grecia 6
KH - Cambogia 6
QA - Qatar 6
RS - Serbia 6
BY - Bielorussia 5
CW - ???statistics.table.value.countryCode.CW??? 5
GE - Georgia 5
MT - Malta 5
SN - Senegal 5
AM - Armenia 4
BS - Bahamas 4
ET - Etiopia 4
HR - Croazia 4
SM - San Marino 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
CY - Cipro 3
Totale 47.399
Città #
Singapore 2.002
Ashburn 1.992
Southend 1.564
Santa Clara 1.489
Hong Kong 918
Fairfield 855
San Jose 851
Chandler 782
Milan 721
Woodbridge 647
Hefei 631
Rome 613
Jacksonville 602
Council Bluffs 599
Houston 516
Bologna 456
Dearborn 446
Ann Arbor 444
Beijing 398
Wilmington 350
Nyköping 335
Seattle 330
Los Angeles 316
Chicago 300
Torino 290
London 282
New York 245
Florence 237
Modena 234
Cambridge 229
Ho Chi Minh City 195
Seoul 194
The Dalles 162
Helsinki 157
Hanoi 152
Catania 150
Dallas 146
Genova 125
Princeton 123
Verona 119
Padova 118
Sofia 117
Izmir 115
Salt Lake City 113
Castelnuovo Rangone 105
Bremen 103
Eugene 102
Moscow 101
Venezia 101
Lauterbourg 96
Turin 96
San Diego 95
Buffalo 94
Napoli 94
Des Moines 93
Munich 89
Mexico City 83
Shanghai 83
São Paulo 83
Palermo 81
Pisa 81
Nuremberg 77
Reggio Nell'emilia 77
Redwood City 76
Naples 74
Bari 71
Orem 66
Trento 66
Columbus 63
Tampa 60
Elk Grove Village 58
Trieste 56
Phoenix 53
Boardman 51
Bolzano 51
Parma 51
Piemonte 50
Jakarta 49
Genoa 48
Falls Church 47
Da Nang 46
Monza 46
Udine 46
Atlanta 45
Oggiono 45
Tokyo 45
Norwalk 44
Chennai 43
Vienna 43
Frankfurt am Main 41
Messina 41
Montreal 39
Toronto 38
Dublin 37
Nanjing 35
Pavia 35
Reggio Emilia 35
Brussels 34
Rio Saliceto 33
Warsaw 33
Totale 25.188
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.306
Ruolo della proteina pneumococcica di superficie PspC nel l’interazione in vitro di Streptococcus pneumoniae con le cellule microgliali 494
Yessotoxin inhibits phagocytic activity of macrophages. 472
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 458
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 458
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 454
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 451
La proteina di superficie PspC di pneumococco conferisce resistenza al killing in vitro di Streptococcus pneumoniae da parte di cellule microgliali in maniera indipendente dal complemento 442
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 436
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 430
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 426
RUOLO BIOLOGICO DI DUE RECETTORI TOLL-SIMILI, TLR2 E TLR4, NELLA RISPOSTA MACROFAGICA A CANDIDA ALBICANS 423
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 405
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 405
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 401
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 400
Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library 380
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 379
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 374
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 371
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 370
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 364
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 364
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. 363
Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia 362
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 360
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 353
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 346
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. 344
Safety and immunogencity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study 341
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 339
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 335
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 329
Contribution of different pneumococcal virulence factors to experimental meningitis in mice 328
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 328
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 324
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 314
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 314
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement 305
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglial cells 305
RUOLO DELLA SUPEROSSIDO DISMUTASI DI Enterococcus faecalis SULLA REATTIVITA’ DELLA MICROGLIA IN VITRO 302
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 296
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? 291
The TIGR4 strain of Streptococcus pneumoniae is phagocytosed but resists intracellular killing by microglia in experimental pneumococcal meningitis 288
Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans 288
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 287
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification 285
New strategies for the prevention and treatment of Helicobacter pylori infection 282
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. 281
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery 281
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 281
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii 280
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin 280
Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: Safety, immunogenicity, and efficacy 280
Attenuation of Pseudomonas aeruginosa Virulence by Pomegranate Peel Extract 279
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments 272
Mutants of Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. 267
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 267
The Spr1875 protein of Streptococcus pneumoniae protects the bacterium from microglia-mediated killing 266
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 264
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 264
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity 263
The Pneumococcal surface protein C (PspC) influences the susceptibility of Streptococcus pneumoniae to microglia 261
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine 259
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 257
Interaction of pneumococcal surface structures with microglia 257
Alterazione delle difese monocito-mediate nei confronti di miceti in presenza di virus erpetici 257
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 256
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G 256
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 250
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 249
Alterazione delle difese monocito-mediate nei confronti di Cryptococcus neoformans in presenza dell’Herpesvirus umano 6 248
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform 246
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 244
Safety and immunogenicity in animals of subunit influenza vaccine given intranasally with mutants of Escherichia coli heat-labile enterotoxin (LT) 241
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis 238
IL MICROARRAY PROTEICO NELL’ANALISI DEI LIQUIDI AMNIOTICI: RICERCA DI MARKER PRECOCI DI INFIAMMAZIONE E/O INFEZIONE CORRELABILI AL PARTO PRETERMINE 236
Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizaztion 234
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis 234
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. 234
Physicochemical characterisation of the pertussis vaccine. 233
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 231
Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy 229
Immunobiological characterization of genetic products, identified from whole genome lambda-display libraries of Pneumococcus 228
RUOLO DI PRODOTTI GENICI IDENTIFICATI MEDIANTE LIBRERIE LAMBDA-DISPLAY DA GENOMA COMPLETO DI PNEUMOCOCCO NELL’INTERAZIONE IN VITRO CON CELLULE MICROGLIALI ED EPITELIALI 223
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity 220
Bordetella 216
Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery 216
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 216
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children 215
LA PROTEINA SPR1875 DI STREPTOCOCCUS PNEUMONIAE PROTEGGE IL BATTERIO DAL KILLING DELLA MICROGLIA 212
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment. 204
Brucella 203
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 202
Risposta differenziale della cellula di microglia ad isolati clinici di Candida albicans con differente genotipo 201
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K 200
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 195
The polisaccharyde capsule is necessary for the development of fatal pneumococcal meningitis in mice 193
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 193
Protective activity of a protein fragment identified by screening of a phage display genomic library of Streptococcus pneumoniae 188
Totale 44.972
Categoria #
all - tutte 134.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.054 0 0 0 0 168 192 194 209 273 206 437 375
2022/20234.240 398 344 313 375 465 519 210 412 470 152 257 325
2023/20242.432 220 236 218 204 364 203 222 207 96 112 130 220
2024/20255.361 228 167 110 360 1.049 735 404 362 561 203 527 655
2025/202610.420 620 472 686 1.584 2.161 656 1.045 442 934 908 526 386
2026/20273.314 509 549 987 1.001 268 0 0 0 0 0 0 0
Totale 47.853